Vaxcyte, Inc. - Director's Dealing 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2024-01-29

Reporting Person: PICKERING GRANT (N/A)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-01-29	Common Stock	M	30000	$1.79	Acquired	405814	Direct
2024-01-29	Common Stock	S	30000	$66.03	Disposed	375814	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-01-29	Stock Option (Right to Buy)	$1.79	M	30000	Disposed	2027-05-17	Common Stock (30000)	Direct

Security	Shares	Ownership
Common Stock	151286	Indirect
Common Stock	151286	Indirect

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.

F2: Shares are held directly by a trust for the benefit of the Reporting Person's daughter.

F3: Shares are held directly by a trust for the benefit of the Reporting Person's son.

F4: Stock Option is fully vested and exercisable.